Crinetics Pharmaceuticals (CRNX) Return on Capital Employed (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.00 |
| Dec 31, 2025 | -713.00 |
| Sep 30, 2025 | -723.00 |
| Jun 30, 2025 | -555.00 |
| Mar 31, 2025 | 199.00 |
| Dec 31, 2024 | 466.00 |
| Sep 30, 2024 | -395.00 |
| Jun 30, 2024 | 207.00 |
| Mar 31, 2024 | 458.00 |
| Dec 31, 2023 | 1,116.00 |
| Sep 30, 2023 | 2,223.00 |
| Jun 30, 2023 | -1,150.00 |
| Mar 31, 2023 | -1,008.00 |
| Dec 31, 2022 | -934.00 |
| Sep 30, 2022 | -134.00 |
| Jun 30, 2022 | -173.00 |
| Mar 31, 2022 | 392.00 |
| Dec 31, 2021 | 836.00 |
| Sep 30, 2021 | 92.00 |
| Jun 30, 2021 | -99.00 |
| Mar 31, 2021 | -774.00 |
| Dec 31, 2020 | -711.00 |
| Sep 30, 2020 | 635.00 |
| Jun 30, 2020 | 1,235.00 |
| Mar 31, 2020 | -1,089.00 |
| Dec 31, 2019 | -793.00 |
| Sep 30, 2019 | -740.00 |
| Jun 30, 2019 | -596.00 |
| Mar 31, 2019 | -345.00 |
| Dec 31, 2018 | 84.00 |